EPS for Novelion Therapeutics (USA) (NVLN) Expected At $-0.29; Last Week Qiwi PLC (QIWI) Analysts

October 13, 2017 - By Peter Erickson

Analysts expect Novelion Therapeutics Inc (USA) (NASDAQ:NVLN) to report $-0.29 EPS on November, 7.They anticipate $0.26 EPS change or 47.27% from last quarter’s $-0.55 EPS. After having $-0.13 EPS previously, Novelion Therapeutics Inc (USA)’s analysts see 123.08% EPS growth. The stock decreased 1.17% or $0.08 during the last trading session, reaching $6.73. About 37,342 shares traded. Novelion Therapeutics Inc (USA) (NASDAQ:NVLN) has risen 31.51% since October 13, 2016 and is uptrending. It has outperformed by 14.81% the S&P500.

Among 7 analysts covering QIWI (NASDAQ:QIWI), 1 have Buy rating, 0 Sell and 6 Hold. Therefore 14% are positive. QIWI had 9 analyst reports since September 2, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Thursday, October 29 by JP Morgan. The company was downgraded on Thursday, February 4 by William Blair. The company was maintained on Thursday, September 3 by JP Morgan. Susquehanna maintained Qiwi PLC (NASDAQ:QIWI) rating on Wednesday, September 2. Susquehanna has “Neutral” rating and $25 target. The firm has “Neutral” rating given on Wednesday, September 2 by UBS. The company was upgraded on Friday, August 18 by VTB Capital. The stock of Qiwi PLC (NASDAQ:QIWI) has “Neutral” rating given on Wednesday, July 26 by Citigroup. On Tuesday, March 15 the stock rating was maintained by JP Morgan with “Neutral”. See Qiwi PLC (NASDAQ:QIWI) latest ratings:

18/08/2017 Broker: VTB Capital Old Rating: Hold New Rating: Buy Upgrade
26/07/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Downgrade

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada biopharmaceutical company. The company has market cap of $125.51 million. The Firm is engaged in development of new standards of care for individuals living with rare diseases. It currently has negative earnings. The Firm is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development.

QIWI plc is a provider of payment services in Russia and the Commonwealth of Independent States . The company has market cap of $1.06 billion. The Company’s network enables payment services across physical, online and mobile channels. It has a 22.67 P/E ratio. The Firm operates in target markets and customer divisions.

The stock increased 0.11% or $0.02 during the last trading session, reaching $17.5. About 176,716 shares traded. Qiwi PLC (NASDAQ:QIWI) has risen 82.66% since October 13, 2016 and is uptrending. It has outperformed by 65.96% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com